Preferred Label : Pontocerebellar hypoplasia, type 2a;
Symbol : PCH2A;
CISMeF acronym : PCH2A; PCH2;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : Pontocerebellar hypoplasia with progressive cerebral atrophy; Volendam neurodegenerative disease; PCH2;
Description : Pontocerebellar hypoplasia (PCH) is a heterogeneous group of disorders characterized
by an abnormally small cerebellum and brainstem. PCH type 2 is characterized by progressive
microcephaly from birth combined with extrapyramidal dyskinesia and chorea, epilepsy,
and normal spinal cord findings (Barth, 1993). For a phenotypic description and a
discussion of genetic heterogeneity of PCH, see PCH1 (607596). - Genetic Heterogeneity
of Pontocerebellar Hypoplasia Type 2 PCH2B (612389) is caused by mutation in the TSEN2
gene (608753) on chromosome 3p25, and PCH2C (612390) is caused by mutation in the
TSEN34 gene (608754) on chromosome 19q13.4. PCH2D (613811) is caused by mutation in
the SEPSECS gene (613009) on chromosome 4p15.2. The TSEN2 and TSEN34 genes encode
catalytic subunits of the tRNA splicing endonuclease, whereas the TSEN54 gene encodes
a noncatalytic subunit. The SEPSECS gene is also involved in tRNA processing,;
Inheritance : Autosomal recessive;
Molecular basis : Caused by mutation in the tRNA splicing endonuclease, subunit 54 gene (TSEN54, 608755.0001);
Prefixed ID : #277470;
Origin ID : 277470;
UMLS CUI : C1848526;
Automatic exact mappings (from CISMeF team)
Broader ORDO disease(s)
Currated CISMeF NLP mapping
DO Cross reference
Genes related to phenotype
HPO term(s)
ORDO concept(s)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to NTBT